Biovectra

Biovectra

featured image of Agilent's $925M Biovectra Buy: Boosting Growth!

Agilent’s $925M Biovectra Buy: Boosting Growth!

BIOT

Agilent is acquiring Biovectra for $925M! 💰 This deal enhances CDMO services, especially in mRNA and gene editing. 🚀📦